HomeAI · summaries
Storia in 18 fonti
Landmark pancreatic cancer treatment paves way for targeting other tricky tumors
Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be next
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
fortune.com
Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…
- ·
cnn.com
Experimental pill promises new hope for deadly pancreatic cancer | CNN
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…
- ·
dailysabah.com
Experimental pill offers breakthrough hope in pancreatic cancer fight
An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...
- ·
inews.co.uk
Why this new pill for a deadly cancer has doctors excited
The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer
- ·
calabria7.news
Tumore al pancreas, svolta dalla ricerca: il farmaco daraxonrasib raddoppia la sopravvivenza (Calabria 7)
Un nuovo studio clinico sta attirando grande attenzione nella comunità scientifica internazionale per i risultati ottenuti nel trattamento del tumore al
- ·
sciencedaily.com
Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most…
- ·
nature.com
Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments
Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumours will be next.
- ·
fanpage.it
Tumore al pancreas, pillola daraxonrasib raddoppia la sopravvivenza: “È una svolta, ho pianto quando ho visto i risultati”
Il farmaco daraxonrasib contro il cancro al pancreas ha dimostrato risultati rivoluzionari in un nuovo studio
- ·
newsbytesapp.com
This drug can double survival time for pancreatic cancer patients
A groundbreaking daily pill has been shown to double survival time for patients battling the world's deadliest cancer, marking a major advancement in medical research.
- ·
virgilio.it
Tumore al pancreas, la nuova cura con compresse di daraxonrasib dà speranza: come funziona la molecola
La molecola daraxonrasib raddoppia la sopravvivenza contro il tumore al pancreas: i dati promettenti dello studio clinico presentati all'Asco
- ·
eu.usatoday.com
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who can get it.
- ·
hindustantimes.com
Revolution Medicines' new cancer pill extends life: ‘Molecular glue’ works, study shows
While the drug is not a cure, researchers say it could meaningfully improve both the length and quality of life for patients with advanced disease. | World News
- ·
cbc.ca
'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows | CBC News
An experimental drug that doubles survival time for pancreatic cancer is being hailed as a breakthrough for combating one of the world's deadliest cancers.
- ·
pharmaceutical-technology.com
ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer - Pharmaceutical Technology
The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer.
- ·
Scientifically Speaking: A pill takes on pancreatic cancer
For decades, the molecular switch that drives most pancreatic cancers was ‘undruggable’. No longer. A new drug has now nearly doubled how long patients live.
- ·
lescienze.it
Il successo di un farmaco contro un tumore "non trattabile" alimenta le speranze per il futuro
Risultati senza precedenti contro un tumore particolarmente difficile da curare stanno alimentando l'ottimismo sul fatto che altri tumori complessi saranno i p…
- ·
scientificamerican.com
Landmark pancreatic cancer treatment paves way for targeting other tricky tumors
Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be next
- ·
statnews.com
Does Revolution Medicines' pancreatic cancer drug have even greater potential?
Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.
- ·
iodonna.it
umore del pancreas, il farmaco orale che apre una nuova speranza
Presentato all’ASCO, daraxonrasib ha mostrato risultati importanti nei pazienti con tumore del pancreas avanzato. Una possibile svolta, anche se l’arrivo in Europa richiederà tempo